Crossmark

Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity

Crossref DOI link: https://doi.org/10.1007/s13181-018-0685-1

Published Online: 2018-10-30

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Toce, Michael S. http://orcid.org/0000-0002-7013-5432
Chai, Peter R.

Burns, Michele M.

Boyer, Edward W.
License Information

Text and Data Mining valid from 2018-10-30
More Information

Article History

Received: 18 May 2018

Revised: 9 October 2018

Accepted: 12 October 2018

First Online: 30 October 2018

Compliance with Ethical Standards

:

: None of the authors have any financial disclosures relevant to this manuscript.

: None.

: Dr. Boyer is supported by the National Institutes of Health 1K24DA037109. Dr. Chai is supported by the National Institutes of Health K23DA044874. Dr. Burns is the Pediatric Toxicology Section Editor for UpToDate®. No funding was provided for the production of this manuscript.

: No honorarium, grant, or other form of payment was given to anyone to produce this manuscript.